AT390135T

Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes

Abstract

Claimed is treatment, preventing and/or control myelodysplasia syndrome method. The specific method comprises, alone or with the second active ingredients, wherein and/or the blood or the transplanting with an of the adjusting immunity compounds or wherein the pharmaceutically acceptable salt, solvate, hydrate, the stereomeride and compound or; the medicine. The special second active ingredients can affect the hemopoiesis. The claimed is suitable for pharmaceutical composition, the sole unit dosage-form and medicament for box of the method of the invention is.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

65 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
41846802United States of AmericaP

Members65

Family members, oldest first
DocumentOfficeKind
CA2477301A1CanadaA1
WO2004035064A1World Intellectual Property Organization (WIPO)A1
AU2003228508A1AustraliaA1
US2004220144A1United States of AmericaA1
EP1487461A1European Patent Office (EPO)A1
KR20050053769ARepublic of KoreaA
MXPA05003888AMexicoA
BR0315315ABrazilA
EP1487461A4European Patent Office (EPO)A4
HK1073427A1Hong Kong, ChinaA1
CN1713917AChinaA
JP2006507271AJapanA
ZA200503025BSouth AfricaB
KR20070020141ARepublic of KoreaA
JP2007045839AJapanA
US7189740B2United States of AmericaB2
KR100711181B1Republic of KoreaB1
US2007196330A1United States of AmericaA1
EP1900369A1European Patent Office (EPO)A1
EP1487461B1European Patent Office (EPO)B1
NZ539533ANew ZealandA
NZ552052ANew ZealandA
AT390135TThis recordAustriaT
DE60319967D1GermanyD1
US7393863B2United States of AmericaB2
AU2008202638A1AustraliaA1
US2008161360A1United States of AmericaA1
PT1487461EPortugalE
DK1487461T3DenmarkT3
SI1487461T1SloveniaT1
ES2304509T3SpainT3
AU2003228508B2AustraliaB2
DE60319967T2GermanyT2
CA2477301CCanadaC
CN101564390AChinaA
CN100579527CChinaC
IL168061AIsraelA
JP4481828B2JapanB2
US2010278779A1United States of AmericaA1
US7863297B2United States of AmericaB2
US2011172273A1United States of AmericaA1
WO2011143147A1World Intellectual Property Organization (WIPO)A1
AU2008202638B2AustraliaB2
AU2012201727A1AustraliaA1
AU2011253161A1AustraliaA1
EP2568983A1European Patent Office (EPO)A1
US8404716B2United States of AmericaB2
US8404717B2United States of AmericaB2
CN103025330AChinaA
JP2013526525AJapanA
US2013202590A1United States of AmericaA1
AU2012201727B2AustraliaB2
AU2014202561A1AustraliaA1
AU2011253161B2AustraliaB2
US2015038444A1United States of AmericaA1
US9056120B2United States of AmericaB2
AU2014202561B2AustraliaB2
BRPI0315315B1BrazilB1
EP3219317A1European Patent Office (EPO)A1
US9925207B2United States of AmericaB2
US2018207185A1United States of AmericaA1
MX358515BMexicoB
US2019269712A1United States of AmericaA1
BRPI0315315B8BrazilB8
US11116782B2United States of AmericaB2